Literature DB >> 3032605

Involvement of iron and iron-catalyzed free radical production in ethanol metabolism and toxicity.

R Nordmann, C Ribière, H Rouach.   

Abstract

Lipoperoxidation, a degradative process of membranous polyunsaturated fatty acids, has been suggested to represent an important mechanism in the pathogenesis of ethanol toxicity on the liver and possibly also on the brain. Catalysis by transition metals, especially iron, is involved in the biosynthesis of free radicals contributing to lipid peroxidation. Although the exact nature of the redox-active iron implicated in this catalysis is still unknown, it has been well established that lipid peroxidation can be prevented in vitro by iron chelators such as desferrioxamine. Deprivation of redox-active iron through desferrioxamine inhibits by about 50% the microsomal oxidation of ethanol in vitro and reduces very significantly in vivo the overall ethanol elimination rate in rats. Administration of desferrioxamine together with ethanol also reduces the ethanol-induced disturbances in the antioxidant defense mechanisms of the hepatocyte. It also reduces in mice both the severity of physical dependence on ethanol and lethality following the acute administration of a narcotic dose of ethanol. Chronic overloading of rats with iron results, on the opposite, in an increased rate of ethanol elimination, although alcohol dehydrogenase and catalase activities are reduced and cytochrome P-450 depleted in the liver of such iron-overloaded animals. The magnitude of the ethanol-induced increase in lipid peroxidation and decrease in the major membranous antioxidant, alpha-tocopherol, is exacerbated in iron-overloaded rats. Several disturbances of iron metabolism have been reported in human alcoholics. Their contribution to ethanol toxicity appears very likely in the case of hepatic siderosis associated with alcohol abuse. Ethanol could however disturb iron metabolism even in the absence of gross abnormalities of the total iron stores. It is suggested that ethanol intoxication could increase cellular redox-active iron, thus contributing to an enhanced steady-state concentration of reactive-free radicals. This oxidative stress would lead to lipoperoxidative damage and cellular injury.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032605     DOI: 10.1159/000469241

Source DB:  PubMed          Journal:  Enzyme        ISSN: 0013-9432


  6 in total

1.  Does iron affect osteoblast function? Studies in vitro and in patients with chronic liver disease.

Authors:  T Diamond; R Pojer; D Stiel; A Alfrey; S Posen
Journal:  Calcif Tissue Int       Date:  1991-06       Impact factor: 4.333

Review 2.  Interaction of alcohol with other drugs and nutrients. Implication for the therapy of alcoholic liver disease.

Authors:  C S Lieber
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Vermal atrophy of alcoholics correlate with serum thiamine levels but not with dentate iron concentrations as estimated by MRI.

Authors:  Matthias Maschke; Johannes Weber; Udo Bonnet; Albena Dimitrova; Julia Bohrenkämper; Sonja Sturm; Bernhard W Müller; Markus Gastpar; Hans-Christopher Diener; Michael Forsting; Dagmar Timmann
Journal:  J Neurol       Date:  2005-03-23       Impact factor: 4.849

Review 4.  Aetiology and pathophysiology of chronic liver disorders.

Authors:  J Schölmerich; A Holstege
Journal:  Drugs       Date:  1990       Impact factor: 9.546

5.  Comparison of antioxidant activities among four kinds of Japanese traditional fermented tea.

Authors:  Masanori Horie; Kazuhiro Nara; Sakiko Sugino; Aya Umeno; Yasukazu Yoshida
Journal:  Food Sci Nutr       Date:  2016-11-22       Impact factor: 2.863

6.  Malfunctioning of the iron-sulfur cluster assembly machinery in Saccharomyces cerevisiae produces oxidative stress via an iron-dependent mechanism, causing dysfunction in respiratory complexes.

Authors:  Mauricio Gomez; Rocío V Pérez-Gallardo; Luis A Sánchez; Alma L Díaz-Pérez; Christian Cortés-Rojo; Victor Meza Carmen; Alfredo Saavedra-Molina; Javier Lara-Romero; Sergio Jiménez-Sandoval; Francisco Rodríguez; José S Rodríguez-Zavala; Jesús Campos-García
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.